Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)

Area of Science:

• Neurocutaneous disorders
• Neurological autoimmune diseases

Background:

• Neurofibromatosis type 1 (NF1) is an autosomal dominant condition associated with increased cancer risk.
• Relapsing-remitting multiple sclerosis (RRMS) is a central nervous system inflammatory demyelinating disease.
• The simultaneous occurrence of NF1 and MS is exceptionally uncommon.

Purpose of the Study:

• To report a rare case of coexisting multiple sclerosis and neurofibromatosis type 1.
• To highlight the successful treatment of a patient with both conditions.

Main Methods:

• Case study of a 31-year-old male presenting with subacute walking difficulties and proximal lower limb pain.
• Treatment with natalizumab was administered.

Main Results:

• The patient with NF1 and MS experienced successful symptom management with natalizumab.
• The case demonstrates a rare clinical presentation of coexisting neurological conditions.

Conclusions:

• The coexistence of MS and NF1, though rare, warrants clinical awareness.
• Proactive follow-up for MS in NF1 patients is vital for early intervention and disability prevention.
• Integrated treatment strategies, including physical therapy, can enhance patient outcomes and quality of life.